MAYNE PHARMA
Lobbying client. Federal LDA filings.
- Source id
72769- General description
- Increasing access to pharmaceuticals
- Country
- AU
- Principal place of business
- AU
- Effective date
- 2026-03-02
- Total spend (across 2 ingested filings)
- $0
Filings (2) — $0
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-21 | Q1 | 2026 | G2G CONSULTING | — |
| 2026-04-21 | RR | 2026 | G2G CONSULTING | — |
Connected on the graph
6 typed relationships in the influence graph — 6 inbound, 0 outbound, grouped by type.
lobbied for (6)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Christopher William Cooper | — | lda_lobbyist_client | |
| — | ← | Katherine M Collins | — | lda_lobbyist_client | |
| — | ← | Nicholas Boggess | — | lda_lobbyist_client | |
| — | ← | Elizabeth Powell | — | lda_lobbyist_client | |
| — | ← | Andrea Harless | — | lda_lobbyist_client | |
| — | ← | Aditya Girish Phd | — | lda_lobbyist_client |